Benefits of intraoral stents for sparing normal tissue in radiotherapy of nasopharyngeal carcinoma: a radiobiological model-based quantitative analysis.

Abstract

BACKGROUND:

To determine the value of individualized intraoral stent for normal tissue sparing in radiotherapy of nasopharyngeal carcinoma (NPC) using quantitative analysis of radiobiological model.

METHODS:

Sixteen patients with NPC who used intraoral stent and 17 patients without intraoral stent were enrolled in this study. All patients underwent Helical Tomotherapy (HT) in our center. Based on the patient's dose volume histogram (DVH), the modified Webb-Nahum model was used to predict tumor control probability (TCP), and the parallel architecture model and Lyman-Kutcher-Burman (LKB) model were used to estimate the normal tissue complications probability (NTCP). The differences of TCP, NTCP and dosimetric parameters between the two groups were compared and analyzed.

RESULTS:

The mean dose metrics of oral cavity, mandible, left and right parotid gland in patients with intraoral stent was significantly decreased by 11.6%, 12.2%, 15.4%, and 8.7% on average, respectively (P<0.05), while the conformity index (CI, P=0.056) and homogeneity index (HI, P=0.676) of the tumor target showed no statistically different. Quantitative assessment of radiobiological model revealed that the NTCP of oral cavity and parotid glands were both significantly lower in patients with intraoral stent than those without intraoral stent (P<0.001), without compromising TCP of the tumor target (P=0.056). For example, patients using intraoral stent significantly reduced oral mucositis and xerostomia complication probability by 2.52% and 10.11% on average compared to unused ones, respectively.

CONCLUSIONS:

The custom-made intraoral stents showed promising value at sparing normal tissue during radiotherapy for NPC without affecting target dose coverage or tumor control.

• Authors: Zhen Hou, Shuangshuang Li, Yuya Jiang, Fangfang Sun, Juan Liu, Shanbao Gao, Weitao Chen, Jing Yan
• Journal: Translational cancer research (Transl Cancer Res) Vol. 10 Issue 10 Pg. 4281-4289 (Oct 2021) ISSN: 2219-6803 [Electronic] China
• PMID: 35116287 (Publication Type: Journal Article)
• Copyright: 2021 Translational Cancer Research. All rights reserved.